Archive · 20 Aug 2025
DCGI: Digitization Speeds Up Drug Approval Process
India is making it faster to approve new medicines!
The government is using digital tools to review drugs, making the process quicker.
Trials for new cell and gene therapies used to take a long time, but now they are much faster.
They also launched a system to check how well each state's drug regulators are doing, so everyone can improve.
Also, they created a shared database to make sure medicines meet international standards.
Digital dashboards have reduced drug approval timelines.
Global Clinical Trial review dropped from 226 to 40 days.
Modifications for cell and gene therapies have decreased in time.
State Drug Regulatory Index was launched.
CDSCO created a national database for pharmaceutical product certification.
- Who
- DCGI, CDSCO, and Ajay Kumar Sood.
- What
- Digitalization speeds up drug approvals.
- When
- Between 2022 and 2024.
- Where
- India
- Why
- To reduce drug approval timelines.
- DCGI
- Rajeev Raghuvanshi
- Event
- Follow-up meeting on drug regulations
- Global Clinical Trials Time Reduction
- From 226 to 40 days
- Modification Time Reduction (2022 to present)
- From 218 to 98 days
- Evaluation System
- State Drug Regulatory Index